Dopamine transporter inhibitors and their use
CA 2389049 A1 · Owner: Enyedy, Istivan · Inventors: Wang, Shaomeng; Kozikowski, Alan; Johnson, Ken
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a novel class of compounds. The compounds are inhibitors of dopamine transporter and therefore are useful in the treatment of disorders related to dopamine transporter activity. One aspect of the present invention provides a class of compounds of formula (I): wherein R1 is an alkyl, aryl, alkyl-aryl, aromatic ring containing one or more hetero atoms; R2 is an alkyl, aryl, aromatic ring containing one or more hetero atoms ketone, hydroxyl, alcohol, aldehyde, ester acid, amide group, or (1) or (2), wherein R' is a phenyl ring optionally substituted with one or more halogens or one or more saturated or unsaturated alkyl (C1-5) group or aromatic ring , with …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.